Dural Manifestation of Langerhans Cell Histiocytosis​: Multimodality Imaging Approach

Nadia Nazir1, Aamna Hassan2, Aasma Ashraf1

  • 1Departments of Radiology.

Insights

Langerhans cell histiocytosis (LCH) can rarely affect the dura. Combined MRI and FDG PET imaging are crucial for diagnosing and managing this rare central nervous system manifestation.

Area of Science:

  • Pediatric Neurology
  • Neuroradiology
  • Oncology

Background:

  • Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disorder of myeloid origin.
  • Dural involvement is an uncommon manifestation of LCH, particularly in pediatric cases.
  • Dural LCH can mimic other conditions like meningioma or pachymeningitis on imaging.

Purpose of the Study:

  • To report a rare case of dural Langerhans cell histiocytosis in a pediatric patient.
  • To highlight the diagnostic utility of combined MRI and FDG PET imaging in CNS LCH.
  • To emphasize the importance of differentiating dural LCH from other dural pathologies.

Main Methods:

  • Case presentation of a 2-year-old boy with LCH presenting with scalp swelling.
  • Detailed description of imaging findings, including MRI and FDG PET.
  • Review of literature regarding dural LCH and its imaging characteristics.

Main Results:

  • The patient presented with scalp swelling, and imaging revealed dural involvement.
  • MRI provided detailed structural and anatomical information of the dural lesion.
  • FDG PET demonstrated metabolic activity, aiding in lesion characterization and staging.

Conclusions:

  • Combined MRI and FDG PET imaging offer complementary information for diagnosing CNS LCH.
  • This multimodal imaging approach is essential for accurate staging and treatment monitoring of dural LCH.
  • Early recognition of dural LCH is critical for appropriate management and improved patient outcomes.

Related Concept Videos